Skip to Main Content

Paper Details

Dosing of Direct Oral Anticoagulants in Patients with Moderate Chronic Kidney Disease in US Clinical Practice: Results from the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF II).
Am J Cardiovasc Drugs
6
2021
AF, CKD, Chronic Kidney Disease, CrCl, Patients, atrial fibrillation, chronic kidney disease, creatinine, patients
Author NameAffiliation
Benjamin A SteinbergUniversity of Utah
Gregg C Fonarowuniversity of california los angeles Division of Cardiology
Gregg C Fonarowuniversity of california los angeles Division of Cardiology
Bernard J GershMayo Clinic College of Medicine
Kenneth W MahaffeyStanford Center for Clinical Research, Stanford University School of Medicine
Daniel E SingerMassachusetts General Hospital and Department of Medicine, Harvard Medical School
Eric D PetersonDuke University Medical Center, Duke Clinical Research Institute
Eric D PetersonDuke University Medical Center, Duke Clinical Research Institute
Jonathan P PicciniDuke University Medical Center, Duke Clinical Research Institute
  • 1 - 9

Datasets

Release 1.2